Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
The United Laboratories International Holdings Limited clinical trials
Also known as TUL.
The registry lists 17 studies whose lead sponsor is The United Laboratories International Holdings Limited or one of 2 companies grouped under it. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the The United Laboratories International Holdings Limited studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to The United Laboratories International Holdings Limited.
- The United Bio-Technology (Hengqin) Co., Ltd.12 studies →Subsidiary
Something wrong?
- Zhuhai United Laboratories Co., Ltd.5 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 17 of 17.
- Comparison of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Biosimilarity of Insulin Aspart 30 Injections After Single-Dose Subcutaneous Administration to Healthy VolunteersNot yet recruitingNCT07875803Not applicable
Sponsor listed in the registry: Zhuhai United Laboratories Co., Ltd.
- Study of UBT37034 InjectionNot yet recruitingNCT07873645Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)RecruitingNCT07659574Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult MalesRecruitingNCT07630233Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)RecruitingNCT07653477Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (OSA-PAP)Not yet recruitingNCT07806851Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.RecruitingNCT07760467Phase 1
Sponsor listed in the registry: Zhuhai United Laboratories Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (OSA-NPAP)Not yet recruitingNCT07767942Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingNCT07785934Phase 1
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)Not yet recruitingNCT07719257Phase 1
Sponsor listed in the registry: Zhuhai United Laboratories Co., Ltd.
- UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)Not yet recruitingNCT07648225Phase 3
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II Clinical Study (CKD)RecruitingNCT07134335Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)RecruitingNCT07145151Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II Study (Overweight or Obesity)CompletedNCT07177469Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- UBT251 Injection Phase II (Type 2 Diabetes Mellitus) StudyCompletedNCT07163624Phase 2
Sponsor listed in the registry: The United Bio-Technology (Hengqin) Co., Ltd.
- Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single-Dose Subcutaneous Administration to Healthy VolunteersCompletedNCT07600944Not applicable
Sponsor listed in the registry: Zhuhai United Laboratories Co., Ltd.
- Comparative Clinical Trial of Pharmacokinetics and Pharmacodynamics of Human Insulin InjectionCompletedNCT07608692Phase 1
Sponsor listed in the registry: Zhuhai United Laboratories Co., Ltd.